Edition:
United States

T2 Biosystems Inc (TTOO.OQ)

TTOO.OQ on NASDAQ Stock Exchange Global Market

8.34USD
3:15pm EDT
Change (% chg)

$0.51 (+6.51%)
Prev Close
$7.83
Open
$7.85
Day's High
$8.49
Day's Low
$7.85
Volume
168,507
Avg. Vol
134,280
52-wk High
$9.98
52-wk Low
$2.51

Chart for

About

T2 Biosystems, Inc. is an in vitro diagnostics company engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company's T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and other abnormalities in a range of unpurified patient sample types, including... (more)

Overall

Beta: 1.26
Market Cap(Mil.): $293.92
Shares Outstanding(Mil.): 36.02
Dividend: --
Yield (%): --

Financials

  TTOO.OQ Industry Sector
P/E (TTM): -- 41.24 33.54
EPS (TTM): -1.82 -- --
ROI: -209.31 14.38 13.09
ROE: -760.70 17.60 15.10

BRIEF-T2 Biosystems Amends Oct. 10, 2014 Supply Agreement With SMC Ltd

* T2 BIOSYSTEMS SAYS ON MAY 16, CO & SMC LTD ENTERED INTO A THIRD AMENDMENT AMENDING CERTAIN SUPPLY AGREEMENT DATED AS OF OCT. 10, 2014 - SEC FILING

May 17 2018

BRIEF-T2 Biosystems Reports Q1 Loss Per Share Of $0.36

* T2 BIOSYSTEMS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 08 2018

BRIEF-T2 Biosystems Files For Non Timely 10-K

* T2 BIOSYSTEMS INC FILES FOR NON TIMELY 10-K - SEC FILING‍​ Source text - http://bit.ly/2ppkjtC Further company coverage:

Mar 19 2018

BRIEF-T2 Biosystems Q4 Revenue Rose 55 Percent To $1.7 Million

* T2 BIOSYSTEMS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND BUSINESS UPDATE

Mar 06 2018

BRIEF-T2 Biosystems Awarded Up To $2 Million By Carb-X To Support Development Of New Tests On The T2Dx Instrument For Drug-Resistant Bacteria

* T2 BIOSYSTEMS AWARDED UP TO $2 MILLION BY CARB-X TO SUPPORT DEVELOPMENT OF NEW TESTS ON THE T2DX INSTRUMENT FOR DRUG-RESISTANT BACTERIA Source text for Eikon: Further company coverage:

Mar 06 2018

BRIEF-T2 Biosystems Says John Sprague Has Been Named CFO

* T2 BIOSYSTEMS INC - JOHN SPRAGUE HAS BEEN NAMED CHIEF FINANCIAL OFFICER Source text for Eikon: Further company coverage:

Feb 05 2018

BRIEF-T2 Biosystems CFO Darlene Deptula-Hicks Resigns

* T2 BIOSYSTEMS- ON JAN 30, DARLENE DEPTULA-HICKS NOTIFIED CO OF HER RESIGNATION FROM POSITION AS CO'S CHIEF FINANCIAL OFFICER EFFECTIVE IMMEDIATELY

Feb 05 2018

BRIEF-T2 Biosystems Says ‍Total Q4 Revenue Is Expected To Exceed Previously Guided Range Of $1.1 Mln To $1.3 Mln​

* T2 BIOSYSTEMS ANNOUNCES PRELIMINARY FOURTH QUARTER 2017 FINANCIAL RESULTS AND PROVIDES UPDATE ON T2BACTERIA PANEL

Jan 04 2018

BRIEF-T2 Biosystems, SMC Ltd Amend Certain Supply Agreement

* T2 BIOSYSTEMS-ON DEC. 22, CO,SMC, LTD ENTERED INTO SECOND AMENDMENT TO SUPPLY AGREEMENT, AMENDING CERTAIN SUPPLY AGREEMENT, DATED AS OF OCT. 10, 2014

Dec 27 2017

Earnings vs. Estimates